However, using the same dose, FM markedly reduced the activation of NF-κB and STAT3, significantly enhanced CD8+NKG2D+ cell-mediated antitumor efficacy in vitro, and exerted an effective therapeutic potency in HCC-bearing mice with intact immune system. The gene discussed is NFKB1; the disease is hepatocellular carcinoma.